Investor Type | Firm |
Type of Fund | VC |
Industries | BioTech • Businesses Solutions • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Consumer • Pharmaceutical (& Medicine) |
Stages | Early, Seed, Series A, Series B |
Investing | United States |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Assets Under Management | $600,000,000 |
The Column Group is a science-driven venture capital firm that makes significant financial and operational commitments to build early stage drug discovery companies based on their unique scientific platforms and potential to deliver multiple breakthrough therapeutics. The firm was founded in 2007 and is headquartered in San Francisco, California.